Skip to main content
Signal8

Mentari Therapeutics, Inc. (MTRI)

Industry: Biotechnology

Mentari Therapeutics, Inc. logo

Mentari Therapeutics, Inc.

NASDAQ:MTRIHealthcare
-11.93%$17.50
CLOSED
AH$17.50+0.00%vs close
Mkt Cap$924.24M
EV-
Float35.49M
O/S52.81M
VOL171K sh
$ Vol$3.08M
RVOL5.22×
Inst Own-
SI<0.1%
Net Cash/Sh-
EarningsFeb 10 · in 3mo
Dilution
Mentari Therapeutics, Inc. logoNASDAQ:MTRIClosed$17.50-11.93%
Pipeline1 lead-sponsored trial·0 active1 completed

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
  • Phase 2
    Completed

    INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa

    INM-755 (cannabinol) cream, Vehicle Cream

    Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional +2

    Enrollment
    19
    Start
    Dec 2021
    Primary Completion
    Apr 2023
    Completion
    Apr 2023
    NCT04908215